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I n recent years,  the number of pharyngeal cancer patients has been increasing.  At the same time,  the 
development of endoscopic imaging technology has 
contributed to an increase in the rate of superficial neo-
plasms among pharyngeal cancer patients [1-3].  For 
superficial cancers,  transoral surgeries such as endo-
scopic mucosal resection (EMR) [4 , 5],  endoscopic 
submucosal dissection (ESD) [6 , 7],  endoscopic laryn-
go-pharyngeal surgery (ELPS) [8],  and transoral video-
laryngoscopic surgery [9] have been performed rather 
than open surgery or radiation chemotherapy,  because 
these procedures are minimally invasive,  can preserve 
the physical function,  and do not impair the patient’s 
quality of life.  Historically,  ESD has frequently been 
adopted for the treatment of esophageal,  gastric,  and 
colonic neoplasms,  although the number of institutions 
performing ESD for superficial cancer of the pharynx is 
increasing in Japan.  Nonetheless,  there have been only 
a few reports on the efficacy and safety of pharyngeal 
ESD,  partly due to the rarity of superficial cancers.  In 
this study,  we retrospectively assessed the efficacy and 
safety of ESDs performed at our institution for the 
treatment of pharyngeal neoplasms.
Acta Med.  Okayama,  2019
Vol.  73,  No.  2,  pp.  109-115
CopyrightⒸ 2019 by Okayama University Medical School.
http ://escholarship.lib.okayama-u.ac.jp/amo/Original Article
Clinicopathological Features and Outcomes of Endoscopic Submucosal  
Dissection for Superficial Cancer of the Pharynx
Makoto Abea＊,  Masaya Iwamuroa,  Yoshiro Kawaharab,  Hiromitsu Kanzakia,   
Seiji Kawanoa,  Takehiro Tanakac,  Munechika Tsumurad,  Takuma Makinod,   
Yohei Nodad,  Hidenori Marunakad,  Kazunori Nishizakid,  and Hiroyuki Okadaa
Departments of  aGastroenterology and Hepatology,  and dOtolaryngology-Head and Neck Surgery,   
Okayama University Graduate School of Medicine,  Dentistry and Pharmaceutical Sciences,   
Departments of  bEndoscopy and cPathology,  Okayama University Hospital,  Okayama 700-8558,  Japan
The efficacy and safety of endoscopic submucosal dissection (ESD) for superficial cancer of the pharynx are still 
unclear.  To identify clinicopathological features of superficial pharyngeal cancer,  and the efficacy and safety of 
ESD,  we retrospectively assessed 70 pharyngeal cancers in 59 patients who underwent ESD.  Of these patients,  
61.0% and 50.8% had a history of esophageal cancer and head and neck cancer,  respectively.  The median tumor 
size was 15 mm,  and 75.7% of the lesions were located at the piriform sinus.  The en bloc resection rate was 
94.9%.  Treatment-related adverse events occurred in 8 cases,  but there was no treatment-related death.  The 
lateral margin was positive for neoplasm in 3 lesions (4.3%) and inconclusive in 27 lesions (38.6%),  but no local 
recurrence was observed.  Cervical lymph node metastasis was observed in 6 patients,  and was successfully 
treated by cervical lymph node dissection.  The three-year overall survival rate was 91.5% (95%CI: 76.6-97.3%) 
and the cause-specific survival rate was 97.6% (95%CI: 84.9-99.7%).  In conclusion,  ESD for superficial pha-
ryngeal cancer was safe and effective.  “Resect and watch” is probably a feasible and rational strategy for treat-
ment of patients with superficial pharyngeal cancer.
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Patients and Methods
We assessed 70 lesions of early cancers in the oro-
pharynx or hypopharynx in 59 patients who underwent 
ESD between September 2006 and February 2017 at the 
Okayama University Hospital.  Prior to ESD,  all 
patients underwent esophagogastroduodenoscopy and 
cervical ultrasound or computed tomography (CT).  
ESD was conducted as one of the treatment options for 
lesions with a preoperative diagnosis of either severe 
dysplasia or a possible node-negative squamous cell 
carcinoma without invasion to the muscle layer.  The 
Ethical Committee of the Okayama University Hospital 
approved this study (no. 1804-012),  which also adhered 
to the Declaration of Helsinki.
ESD procedures. All procedures were performed 
by one of the 2 endoscopists who had previously per-
formed > 500 ESDs for esophageal,  gastric,  and colonic 
neoplasms.  Patients were placed in a supine position 
and intubated.  ESD was performed under general anes-
thesia.  To make an adequate working space,  an otorhi-
nolaryngologist lifted the larynx with a direct laryngo-
scope and fixed it on the ventral side of the intubation 
tube (Fig. 1).  Using a Q260J scope (Olympus,  Tokyo) 
with a lucent hood (F-030; Top,  Tokyo) on its tip,  the 
endoscopist confirmed the location of the lesion and the 
operability of the scope.  The extent of the lesion was 
demarcated using iodine dye,  and the margin was cir-
cumferentially marked with a Dual knife (KD650;  
Olympus) and an electrosurgical generator unit (VIO 
300D; ERBE,  Tübingen,  Germany) set at 40 W for the 
soft coagulation mode (Fig. 2).  For submucosal injec-
tion,  a solution of indigo carmine with glycerol was 
used.  A mucosal incision was made around the lesion 
with the Dual knife in VIO endo cut I mode (effect 
1; Fig. 3),  and submucosal dissection was performed 
using the Dual knife and a Mucosectom (Pentax 
Medical,  Tokyo) in swift coagulation mode at 40 W 
(effect 3; Fig. 4).  In cases with difficult maneuverabil-
ity,  an otorhinolaryngologist inserted a nasopharyngo-
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Fig. 1　 To make an adequate working space,  an otorhinolaryn-
gologist lifted the larynx with a direct laryngoscope and ﬁxed it on 
the ventral side of the intubation tube.
Fig. 2　 The extent of the lesion was demarcated using iodine dye,  
and the margin was circumferentially marked with a Dual knife 
(KD650; Olympus) and an electrosurgical generator unit (VIO 
300D; ERBE,  Tübingen,  Germany) set at 40 W for a soft coagula-
tion mode.
Fig. 3　 For submucosal injection,  a solution of indigo carmine 
with glycerol was used.  Incision of mucosa was made around the 
lesion with a Dual knife in VIO endo cut I mode (eﬀect 1).
laryngoscope to grasp and tow the lesion (Fig. 5).
Histological evaluations. Resected specimens 
were extended on a board,  fixed in 10% formalin for 24 
hours and sectioned at 2-mm intervals.  The tumor size,  
specimen size,  lateral and vertical margins for neo-
plasm,  and lymphovascular invasion were assessed.
Management after ESD. After removal of the 
endotracheal tube,  a swallowing function test was per-
formed by an otolaryngologist on a daily basis before 
starting oral intake.  CT scanning and endoscopic sur-
veillance were performed every 6 months to detect 
lymph node metastasis,  local recurrence,  and meta-
chronous cancers of the mouth,  pharynx,  larynx,  and 
esophagus.  Metachronous cancer was defined as a 
lesion detected 12 months or more after ESD.
Statistical analysis. The primary outcomes of this 
study were the incidence of short-term adverse events 
and long-term cause-specific and overall survival rates.  
In this study,  we included the cases who received sub-
sequent ESD for metachronous cancer in the analysis of 
short-term outcomes because frequent occurrence and 
repetition of ESD is characteristic of pharyngeal cancer.  
Long-term outcomes were analyzed by using the 
Kaplan-Meier method.
Results
Patients and lesion characteristics. We per-
formed ESD for 70 lesions in 59 patients during the 
study period (Table 1).  The mean age of the patients 
was 66.0 years.  Thirty-six patients (61.0%) had esopha-
gus squamous cell carcinoma (ESCC),  which was pre-
viously diagnosed or treated in 22 patients (37.3%) and 
synchronously diagnosed in 15 patients (25.4%).  Head 
and neck squamous cell carcinoma (HNSCC),  other 
than early cancers in the oropharynx or hypopharynx 
treated with ESD,  was found in 30 patients (50.8%).  
Twenty-nine patients (49.2%) had previously diagnosed 
or treated HNSCCs,  and 4 patients (7.0%) had syn-
chronous HNSCC.  In 27 patients (45.8%),  oropharyn-
geal and hypopharyngeal cancers were found during a 
follow-up examination of ESCC or a preoperative 
examination for ESCC.  The median tumor size of the 
oropharyngeal and hypopharyngeal cancers was 
15 mm,  and 53 lesions (75.7%) were located in the pir-
iform sinus.
Procedure outcomes. The en bloc resection rate 
was 94.9% (Table 2).  The median fasting period was 4 
days.  Treatment-related adverse events occurred in 8 
cases.  Aspiration pneumonia developed in 6 cases and 
was treated with antibiotics.  One patient who under-
went laryngopharyngectomy prior to ESD developed 
hypopharyngeal stenosis and was treated by balloon 
dilation.  There were no treatment-related deaths.
Histopathological outcomes. Of the 70 lesions,  
the horizontal margin was positive for neoplasm in 3 
lesions (4.3%) and inconclusive in 27 lesions (38.6%) 
(Table 3).  The vertical margin was positive in 2 lesions 
(2.9%).  Subepithelial invasion was observed in 27 
lesions (38.6%).  Three lesions had vascular invasion,  
and 4 lesions had lymphatic invasion.  One lesion had 
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Fig. 4　 Submucosal dissection was performed using a Dual knife 
with Mucosectom in swift coagulation mode at 40 W (eﬀect 3).
Fig. 5　 In cases with diﬃcult maneuverability,  an otorhinolaryn-
gologist inserted a nasopharyngolaryngoscope to grasp and tow the 
lesion.
both the vascular and lymphatic invasions.  Sub-
epithelial invasion was observed in all of the 6 lesions 
that had lymphovascular invasion.
Clinical course of the patients and long-term out-
comes. The median follow-up period was 35.5 
months (range 2-119 months).  No patients with a pos-
itive or inconclusive horizontal margin received radia-
tion therapy postoperatively.  However,  none of the 
patients developed local recurrence.  Among the 2 
patients with a positive vertical margin,  one patient 
received radiation therapy postoperatively.  However,  
the patient died of primary pharyngeal cancer after 23 
months.  The other patient did not develop local recur-
rence.  Seven patients developed cervical lymph node 
metastasis 1.2 to 54 months (median 8.5 months) after 
endoscopic resection of hypopharyngeal cancers.  These 
patients were successfully salvaged with lymph node 
dissection.  Eight patients died during the follow-up 
period.  Only one patient died of pharyngeal cancer.  
Nine patients developed metachronous pharyngeal can-
cer at 24 months (range 13-52 months) after endoscopic 
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Table 1　 Characteristics of patients and lesions
n %
Median age (range in years) 66
(41-91)
Sex
　Male 57 97
　Female 2 3
History of ESCC 36 61
　Previous ESCC 22 37
　Synchronous ESCC 15 25
History of HNSCC 30 51
　Previous HNSCC 29 49
　Synchronous HNSCC 4 7
The purpose of examination
　Follow-up after treatment or preoperative examination of HNSCC 19 32
　Follow-up after treatment or preoperative examination of ESCC 27 46
　Follow-up after treatment or preoperative GI cancer 5 9
　Follow-up after treatment of benign disease 3 5
　Screening 5 9
　Symptom 5 9
Lesions 70
Tumor size, mm (range) 15
(2-40)
Location
　Hypopharynx 61 87
　　Piriform sinus 53 76
　　Posterior wall 4 6
　　Postcricoid 2 3
　Oropharynx 8 11
　　Posterior wall 6 9
　　Lateral wall 2 3
　Other 1 1
ESCC,  esophageal squamous cell carcinoma; HNSCC,  head and neck squamous cell carcinoma; GI,  gastrointestinal.
Table 2　 Procedure outcomes
n %
Number of procedures 59 100
En bloc resection 56 94.9
Adverse event  8 13.6
　Aspiration pneumonia  6 10.2
　Hematoma  1 1.7
　Stenosis  1 1.7
　Pharyngitis  1 1.7
Fasting period,  median (range),  d  4 (1-28)
Hospital stay,  median (range),  d 11 (9-52)
resection.  The 3-year overall survival rate was 91.5% 
(95%CI: 76.6-97.3%) and the cause-specific survival 
rate was 97.6% (95%CI: 84.9-99.7%).
Discussion
In this study,  we evaluated patients who underwent 
pharyngeal ESD and found that the 3-year overall sur-
vival rate was 91.5% and the cause-specific survival rate 
was 97.6%.  Short-term adverse events were observed 
in 13.6% of cases.  ELPS is one of the treatment meth-
ods that can be used to safely perform en bloc resection 
of early pharyngeal cancers.  ESD is conducted with 
endoscopy devices through the forceps hole of an endo-
scope and is mainly performed by gastroenterologists,  
whereas otorhinolaryngologists directly manipulate the 
surgical devices in ELPS.  Tateya et al.  reported that the 
3-year overall and disease-specific survival rates of 
patients who underwent ELPS for 104 superficial laryn-
gopharyngeal cancers were 90% and 100%,  respec-
tively,  which were similar to our results [9].  ESD or 
ELPS is conducted as one of the treatment options for 
lesions with a preoperative diagnosis of a possible 
node-negative superficial laryngopharyngeal cancer 
based on the morphology of the lesion.  Therefore,  
indications are not different between ESD and ELPS.  
Radiation therapy is another modality that allows for 
laryngeal preservation in patients with head and neck 
cancer.  Radiation can be applied to locally advanced 
oropharyngeal cancers,  in addition to superficial lesions.  
Nakamura et al.  reported the results of radiation ther-
apy for early hypopharyngeal cancer; the overall and 
disease-specific 5-year survival rates for 95 patients 
without synchronous malignancies were 66.0% and 
77.4%,  respectively [10].  However,  because there have 
been no studies comparing the effectiveness of ESD,  
ELPS,  and radiation therapy for the treatment of early 
pharyngeal cancers,  the treatment strategies have 
tended to differ among institutions.  Future studies 
investigating the efficacy and safety of these procedures 
will be needed.
In the present study,  50.8% of the patients had a 
previous history of or synchronous HNSCC.  Moreover,  
61.0% of the patients had a previous history of or syn-
chronous ESCC.  It has been reported that synchronous 
or metachronous HNSCC and ESCC are identified in 
7.8-44.1% and 39.2-85.6%,  respectively,  of patients with 
pharyngeal cancers [5 , 11-13].  It is noteworthy that 
70.0% of the lesions were detected during a follow-up 
period after the treatment or preoperative screening of 
HNSCC or ESCC.  These results reinforce the impor-
tance of a strict follow-up examination of newly devel-
oped pharyngeal superficial cancers in patients with 
esophageal cancer or head and neck cancer.  Drinking,  
smoking and alcohol flushing have been reported as risk 
factors for developing pharyngeal cancers [14-17].  
Morimoto et al.  reported that pharyngeal screening was 
useful to detect early pharyngeal cancers in patients 
who underwent ESD for superficial esophageal cancers 
[18].  Careful observation of the pharynx in these 
patients is considered important.
The most common adverse events after ESD of pha-
ryngeal cancers are aspiration pneumonia and subcuta-
neous emphysema.  It has been reported that aspiration 
pneumonia and subcutaneous emphysema occur in 
4-14.3% and 2-6%,  respectively,  of patients [11-
13 , 19 , 20].  In this study,  treatment-related adverse 
events developed in 13.6% of patients.  Among these 
events,  aspiration pneumonia was most frequent,  
accounting for 10.2% of cases (6 patients).  It is likely 
that pharyngeal ESD adversely affects swallowing func-
tion.  Therefore,  physicians should be aware of the 
potential for aspiration pneumonia after pharyngeal 
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Table 3　 Histopathological outcomes
n %
Number of lesions 70 100
Histology of specimens
　Squamous cell carcinoma 68 97.1
　High grade dysplasia  1 1.4
　Low grade dysplasia  1 1.4
Lateral margin
　Positive  3  4.3
　Negative 40 57.1
　Inconclusive 27 38.6
Vertical margin
　Positive  2  2.9
　Negative 68 97.1
Vascular invasion
　Positive  3  4.3
　Negative 67 95.7
Lymphatic invasion
　Positive  4  5.7
　Negative 65 94.3
Specimen size,  mm (range) 24 (7-55)
Tumor depth
　Epithelium 43 61.4
　Subepithelium 27 38.6
ESD.  As a long-term adverse event,  deterioration of 
swallowing function is a concern after transoral surgery.  
Tomifuji et al.  reported that although the percutaneous 
endoscopic gastrostomy dependency rate is quite low in 
transoral surgery,  resection of the piriform sinus and 
arytenoid,  pulmonary dysfunction,  and large mucosal 
defect were associated with postoperative dysphagia 
[21].  Because there has been no report on the swallow-
ing function observed long after ESD or ELPS,  further 
studies are anticipated.
The en bloc resection rate of our institution was 
94.9%.  A similar rate (77.4-100%) has been reported 
from other institutions [11-13 , 19 , 20].  Although the 
horizontal margin was positive in 4.3% and inconclu-
sive in 38.6% of the lesions,  local recurrence was not 
observed even in patients who did not undergo adju-
vant therapy.  The relatively higher rate of lesions with 
an inconclusive horizontal margin might have resulted 
from our attempt to resect the lesions as minimally as 
possible in order to reduce a postoperative adverse 
event.  An unclear tumor margin sometimes occurs 
owing to crush or burn damage during the ESD proce-
dure.  In such cases,  a close observation for possible 
burn effects from the ESD is acceptable.  In this study,  
local recurrence was not observed in patients with a 
positive horizontal margin,  suggesting that our strate-
gies — that is,  determining the extent of the lesion 
based on iodine staining and resecting the specimen as 
minimally as possible — are appropriate.
Cervical lymph node metastasis occurred in 6 
patients (7 lesions) during the follow-up period 
(median 35.5 months).  In all 6 of these patients,  the 
pharyngeal lesion that had been resected by ESD had 
infiltrated to the subepithelium.  Moreover,  4 lesions 
had lymphovascular invasion.  Conversely,  lesions with 
carcinoma in situ had no lymphovascular invasion or 
emergence of lymph node metastasis during the fol-
low-up period.  All patients with cervical lymph node 
metastasis were successfully treated by the cervical 
lymph node dissection.  These results indicate that early 
pharyngeal cancers with subepithelial invasion or lym-
phovascular invasion should be strictly followed up for 
metastatic tumors [22].  It is also important to perform 
an en bloc resection of pharyngeal superficial cancers by 
oral surgery,  including ESD,  and a thorough histo-
pathological evaluation in order to investigate the risk of 
lymph node metastasis.
For superficial pharyngeal cancers,  a “resect and 
watch” strategy has been proposed as an option after 
endoscopic resection of the lesions.  In the “resect and 
watch” approach,  patients with a possible incomplete 
endoscopic resection are observed until the develop-
ment of secondary diseases,  such as local recurrence,  
neck lymph node metastasis,  and metachronous pha-
ryngeal cancer without receiving additional treatments 
such as radical surgical resection and radiation therapy.  
Imai et al.  applied this strategy and reviewed 32 patients 
with 47 lesions of superficial pharyngeal cancer [23].  
The authors reported that,  during the median follow-up 
period of 43 months,  local recurrence (n = 4),  neck 
lymph nodes metastasis (n = 5),  and metachronous 
pharyngeal cancers (n = 6) were observed and these 
lesions were successfully treated by a local resection or 
neck dissection.  The 5-year overall survival rate was 
84.4% and the cause-specific survival rate was 100%.  In 
our present series,  we similarly found that the 3-year 
overall survival rate was 91.6% and the cause-specific 
survival rate was 97.6%,  indicating that the “resect and 
watch” strategy is feasible for the treatment of superfi-
cial pharyngeal cancers.
This study has several limitations.  First,  this is a 
single-centered,  retrospective study.  Second,  although 
the surgeons who performed the ESD had considerable 
experience with endoscopic tumor resection of the gas-
trointestinal tract,  they were only two in number.  
Therefore,  multi-centered,  prospective studies will be 
needed to determine the usefulness and safety of ESD 
for superficial pharyngeal cancers.
In conclusion,  we revealed that ESD for superficial 
pharyngeal cancers resulted in a 3-year overall survival 
rate of 91.5% and a cause-specific survival rate of 
97.6%.  Although physicians must be mindful of the 
potential for short-term adverse events such as aspira-
tion pneumonia,  “resect and watch” is probably a feasi-
ble and rational strategy for the treatment of patients 
with superficial pharyngeal cancers.
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